Logo

Lincoln Pharma Share Price

Lincoln Pharma (INR)803.9-3.8   (-0.5%)

Exchange ScripsBSE531633NSELINCOLNISININE405C01035

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Lincoln Pharma Performance

Market performance
Open price806.65
High828
Volumes55225
Prev Close803.9
Low786.85
Closing date2025-01-10
Historical performance
1 Year High979.50
3 Year High979.50
5 Year High979.50
1 Year Low534.80
3 Year Low255.00
5 Year Low85.05

Lincoln Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
1599
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
17.26
Dividend Yield
Dividend Yield
0.02 %

Lincoln Pharma Investment Returns

1 Year
26.5%
3 Years
121.1%
5 Years
296.2%
10 Years
N/A

Lincoln Pharma Technicals

IndicatorsValueSignal
5-DMA814.91Bearish
10-DMA821Bearish
20-DMA831.59Bearish
50-DMA762.43Bullish
100-DMA733.04Bullish
200-DMA672.84Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters2525252526
Foreign Investors---------------
Domestic Investors2525252526
Public Investors3130529942313502929128644
Government---------------

Lincoln Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income34422510057
Operating Profit134311171055928
Interest15201516
Depreciation106928176
Profit Before Tax12221005959837
Consolidated Net Profit933729694623
Adjusted EPS47363531

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital200200200200
Total Reserves5728482441283464
Minority Interest------------
Total Non-Current Liabilities152380110261
Total Liabilities7254636555464873
Capital Work in Progress356716117
Total Assets7254636555464873

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities632393761693
Cash Flow from Investing Activities-573-366-781-642
Cash Flow from Financing Activitie-52-45-26-57
Net Cash Inflow / Outflow7-19-45-7
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 17.26.
  • 3Y Stock Price CAGR of the stock is 30.6.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹1343 Million.
  • The company generated revenue of ₹5805 Million in the previous financial year.

Lincoln Pharma

803.9-3.8   (-0.5%)

Investment Amount: ₹ 67875
Current Value: ₹ 80390
Performance: 18.4%
P/L: ₹ 12515
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month